Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|December 19, 2012
Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycinElisabet O Berge, Johanna Huun, Johan R Lillehaug, et al.
Plos One|August 30, 2008
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancerRanjan Chrisanthar, Stian Knappskog, Erik Løkkevik, et al.
Molecular Oncology|May 26, 2015
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivoStian Knappskog, Elisabet O Berge, Ranjan Chrisanthar, et al.
Annals of Internal Medicine|January 17, 2018
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer RiskPer E Lønning, Elisabet O Berge, Merete Bjørnslett, et al.
Pageof 1